Skip to main content
OpenTrials

Clinical trial condition

Recurrent Grade 2 Follicular Lymphoma

Explore clinical trials studying Recurrent Grade 2 Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

109 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Grade 2 Follicular Lymphoma trial results

Active, Not Recruiting

Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma

NCT02520791

Conditions
Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +29 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma

NCT01849263

Conditions
Grade 3a Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Metro Minnesota Community Oncology Research Consortium Saint Louis Park, Minnesota, United States
View all 13 locations
View Trial Details

Related conditions